I

Icure Pharmaceutical Inc
KOSDAQ:175250

Watchlist Manager
Icure Pharmaceutical Inc
KOSDAQ:175250
Watchlist
Price: 2 170 KRW 11.91% Market Closed
Market Cap: ₩81.5B

Dividends

Icure Pharmaceutical Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for Icure Pharmaceutical Inc is .

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Icure Pharmaceutical Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Icure Pharmaceutical Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

Price
Icure Pharmaceutical Inc

Annual Price Range
2 170
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -34.54%
Standard Deviation of Annual Returns 41.05%
Max Drawdown -91%
Shares Statistics
Market Capitalization 81.1B KRW
Shares Outstanding 37 560 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

Icure Pharmaceutical Inc's latest stock split occurred on Dec 14, 2022

The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.

Before the split, Icure Pharmaceutical Inc traded at 3734.9999 per share. Afterward, the share price was about 3555.

The adjusted shares began trading on Dec 14, 2022. This was stock split number 4 in Icure Pharmaceutical Inc's history, following the previous one in Oct 21, 2022.

Pre-Split Price
3 112.4999 3 734.9999
Post-Split Price
3 555
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett